Gazing into the future – the next 100 years. Perspectives from diabetologists
DOI:
https://doi.org/10.15277/bjd.2022.399Keywords:
insulin centenary, next 100 years of diabetes, diabetes, immunotherapy in type 1 diabetes, diabetes technology, worldwide diabesity pandemic, dual hormone agonists, EndoBarrier, bariatric surgeryReferences
Greenwood R, Shaw KM. The Silver Jubilee of the ABCD: the early history of the Association. Br J Diabetes 2022;22(1):54-7. https://doi.org/ 10.15277/bjd.2022.346
The ABCD Diabetes Technology Network. See: https://abcd.care/dtn (accessed 13 December 2022).
Young Diabetologists and Endocrinologists’ Forum (YDEF). See: https://www.youngdiabetologists.org.uk/ (accessed 13 December 2022).
Dayan CM. The beginning of the end for insulin? – enter immunotherapy for T1DM. Br J Diabetes 2022;22(Supp1):S65-S68. https://doi.org/ 10.15277/bjd.2022.369
Crabtree TSJ, Ryder REJ, Wilmot EG. #We are not waiting - DIY APS. Do-It-Yourself Artificial Pancreas Systems: The story so far. Br J Diabetes 2022;22(Supp1):S82-S84. https://doi.org/10.15277/bjd.2022.373
Boughton CK, Hovorka R. #We don't have to wait any more. Closed loop systems: transforming the landscape. Br J Diabetes 2022;22(Supp1):S85- S89. https://doi.org/10.15277/bjd.2022.374
Leelarathna L, Choudhary P. Dual-hormone Automated Insulin Delivery. Br J Diabetes 2022;22(Supp1):S69-S71. https://doi.org/10.15277/bjd. 2022.370
Cheah YS. Islet cell transplantation. Br J Diabetes 2022;22(Supp1):S48- S51. https://doi.org/10.15277/bjd.2022.364
Docherty K. A journey from the insulin gene to reprogramming pancreatic tissue. Br J Diabetes 2022;22(Supp1):S72-78. https://doi.org/10.15277/ bjd.2022.371
International Diabetes Federation. IDF diabetes atlas, 10th ed. 2021. https://www.diabetesatlas.org/ (accessed 13 December 2022).
Taylor R. Type 2 diabetes: the problem and the solution. Br J Diabetes 2022;22(Supp1):S55-58. https://doi.org/10.15277/bjd.2022.366
Bain SC. Fat – pharmacological therapies. Br J Diabetes 2022; 22(Supp1):S59-S61. https://doi.org/10.15277/bjd.2022.367
Ryder REJ, Yadagiri M, Burbridge W, et al. Duodenal-jejunal bypass liner for treatment of T2DM and obesity: 4-year outcomes in the first National Health Service (NHS) EndoBarrier service Br J Diabetes 2022;22:82-86. https://doi.org/10.15277/bjd.2022.351
McGowan B. Fat: bariatric surgery and procedures. Br J Diabetes 2022;22(Supp1):S62-S64. https://doi.org/10.15277/bjd.2022.368
Hattersley AT, Patel KA. Precision diabetes: learning from monogenic dia- betes. Diabetologia 2017;60(5):769-77. https://doi.org/10.1007/s00125- 017-4226-2. Epub 2017 Mar 17. PMID: 28314945; PMCID: PMC5907633.
Ahlqvist E, Storm P, Käräjämäki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 2018;6(5):361-9. https://doi.org/10.1016/S2213-8587(18)30051-2. Epub 2018 Mar 5. PMID:29503172.
Downloads
Published
Issue
Section
License
Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.
